FUJIFILM Company’s Life Sciences Group firms, a portfolio of companies providing merchandise, providers and complete options that span all levels of therapeutic improvement from discovery by means of to commercialization, as we speak introduced new names and identities as a part of a strategic positioning effort. The Group Firms’ new names, collaborative strategic focus, and structural alignment displays Fujifilm’s dedication to Life Sciences, providing absolutely built-in, end-to-end options throughout the drug improvement lifecycle—from analysis and discovery to scientific and business manufacturing.
FUJIFILM Irvine Scientific, headquartered in Santa Ana, California rebrands as FUJIFILM Biosciences beneath this new construction and technique. The brand new title encompasses FUJIFILM Biosciences’ evolution over the previous 55 years – from its formation in 1970 to its latest enlargement to serve broader life sciences communities and prospects. It’s also a nod to its scientific roots as a pioneer within the cell tradition media business with a core deal with innovation and high quality. As we speak, FUJIFILM Biosciences presents a complete portfolio of discovery and analysis reagents, recombinant development elements and proteins, specialty chemical substances, and significant assay supplies along with its strong cell tradition media and dietary supplements options within the U.S. The brand new model title will take impact instantly, and the authorized entity title change shall be efficient January 1, 2026.
FUJIFILM Diosynth Biotechnologies, a number one international contract improvement and manufacturing group (CDMO), first acquired by the Fujifilm Group in 2011, rebrands to FUJIFILM Biotechnologies. The Firm serves its international companions providing capabilities for course of improvement by means of business provide, with world-class manufacturing operations throughout Europe, and the U.S. The Firm’s authorized title is not going to change.
Over the previous 15 years, Fujifilm has invested over $10 billion by means of expansions and acquisitions to construct its end-to-end life sciences capabilities to create an accelerated path towards larger affected person entry for superior care.
“Beneath the ‘Companions for Life’ umbrella, our Life Sciences Group firms supply full options to the pharmaceutical and biotechnology markets, aligning with each our strategic development plans and dedication to innovation,” commented Toshihisa Iida, director, company vp, normal supervisor of Life Sciences Technique Headquarters and Bio CDMO Division, FUJIFILM Company, Japan. “By redefining our Life Sciences Group, we additionally help Fujifilm’s development technique for the life sciences sector, the place we consider that unifying beneath a single banner will simplify engagement for our international community of shoppers throughout all the product improvement and biomanufacturing spectrum. It is a chance to make sure the groups in all our Life Sciences firms share the identical technique and robust sense of function. By combining our proprietary applied sciences, comparable to AI and sensing, which have been cultivated within the fields of imaging and healthcare, we create new worth and help pharmaceutical firms, biotech companies, and academia in each drug discovery help options and CDMO providers.”
“FUJIFILM Biosciences focuses on supporting our companions of their life sciences ambitions and doing what we are able to to allow their success alongside the way in which,” mentioned Brandon Pence, president and chief working officer, FUJIFILM Biosciences. “Our basis relies upon the core ideas of placing our individuals first, remodeling by means of innovation and science, and sustaining a dedication to unprecedented customer support. In doing these issues proper, we create sturdy relationships, each internally and externally. We’re enthusiastic about this evolution in our enterprise and welcome the chance to develop our constructive affect on prospects by means of broader capabilities and collaborating with them on future options.”
At FUJIFILM Biotechnologies, we take immense satisfaction within the worth we carry to our companions on a regular basis to assist carry life-changing medicines to sufferers,”
This nearer coordination and united focus strengthens how we work together and ship for our prospects. Collectively, we provide deep information and expertise, velocity, flexibility, and scientific rigor—vital components in bringing advanced biologics to life.”
Lars Petersen, president and chief govt officer, FUJIFILM Biotechnologies
Alongside FUJIFILM Biosciences and FUJIFILM Biotechnologies, the Fujifilm Life Sciences Group firms additionally embody FUJIFILM Mobile Dynamics, a number one developer and producer of human induced pluripotent stem cells, FUJIFILM Wako Pure Chemical Company, and FUJIFILM Toyama Chemical Co., Ltd.